Proprotein convertase subtilisin/Kexin type 9 (PCSK9) single domain antibodies are potent inhibitors of low density lipoprotein receptor degradation
J Biol Chem
.
2016 Dec 16;291(51):26586.
doi: 10.1074/jbc.A116.717736.
Authors
Elodie Weider
,
Delia Susan-Resiga
,
Rachid Essalmani
,
Josée Hamelin
,
Marie-Claude Asselin
,
Surendra Nimesh
,
Yahya Ashraf
,
Keith L Wycoff
,
Jianbing Zhang
,
Annik Prat
,
Nabil G Seidah
PMID:
27986868
PMCID:
PMC5159516
DOI:
10.1074/jbc.A116.717736
No abstract available
Publication types
Published Erratum